G1 Therapeutics (GTHX) P/FCF US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -9.69 | -8.14 | -3.24 | 0.00 | 0.00 | -10.0 | |||
| Changes by years, y/y, % | +14% | -16% | -60% | -100% | -100.0% | ||||
G1 Therapeutics. P/FCF
G1 Therapeutics. P/FCF, changes, %
G1 Therapeutics (GTHX) P/FCF US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| P/FCF | -1.92 | 0.00 | 0.00 | 0.00 | 0.00 | -10.0 | ||
| Changes by years, y/y, % | +33% | -100% | -100% | -100% | ||||
| Changes by quarters, q/q, % | +67% | -100% | ||||||